𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression changes in blood as a putative biomarker for Huntington's disease

✍ Scribed by Luca Lovrecic; Andrej Kastrin; Jan Kobal; Zvezdan Pirtosek; Dimitri Krainc; Borut Peterlin

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
176 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Several studies demonstrated alterations of gene expression in blood in various neurological disorders including Huntington's disease (HD). Using microarray technology, a recent study identified a large number of significantly altered mRNAs in HD blood, from which a 12‐gene set was selected as classifier for discriminating controls and HD patients. The aim of our study was to validate expression changes of these 12 genes in an independent cohort of HD patients and evaluate their sensitivity and specificity. Four different subject groups were includedβ€”patients with HD, Parkinson's disease (PD), acute ischemic stroke (AS) and healthy controls. Although the previous results were successfully validated, gene expression changes in HD blood partly overlapped with those observed in blood from PD and AS patients. Predictive value of the selected biomarker set for HD group was 78%, with 82% sensitivity and 53% specificity. Further gene expression analyses in longitudinal studies are needed to validate and refine possible transcriptomic blood biomarkers in HD. Β© 2009 Movement Disorder Society

πŸ“œ SIMILAR VOLUMES

Neural expression of the Huntington's di
Neural expression of the Huntington's disease gene as a chordate evolutionary novelty
✍ Kauffman, Jeffrey S. ;Zinovyeva, Anna ;Yagi, Kasumi ;Makabe, Kazuhiro W. ;Raff, πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 376 KB πŸ‘ 1 views

## Abstract Huntington's disease is a progressive neuro‐degenerative disorder in humans, which is scharacterized by onset of dementia, muscular ataxia, and death. Huntington's disease is caused by the expansion of the polyglutamine (polyQ) tract in the N‐terminus of the HD protein (Huntingtin). CAG

Changes in the repair capacity of blood
Changes in the repair capacity of blood cells as a biomarker for chronic low-dose exposure to ionizing radiation
✍ Ulla G. Plappert; Bernd Stocker; Helga Fender; Theodor M. Fliedner πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

The purpose of this study was to examine whether changes in the repair capacity of blood cells could be used as a valuable biomarker for radiation exposure. To characterize the repair kinetics in nonirradiated and irradiated cells we first performed in vitro split dose experiments. DNA damage and DN

Age-dependent and tissue-specific CAG re
Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene
✍ Hiroshi Ishiguro; Kouji Yamada; Hirohide Sawada; Kazuhiro Nishii; Naohiro Ichino πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 479 KB πŸ‘ 1 views

## Abstract Huntington's disease (HD) is a neurodegenerative disorder characterized by the expansion of CAG repeats in exon 1 of the HD gene. To clarify the instability of expanded CAG repeats in HD patients, an HD model mouse has been generated by gene replacement with human exon 1 of the HD gene

Translated mutation in the Nurr1 gene as
Translated mutation in the Nurr1 gene as a cause for Parkinson's disease
✍ David A. Grimes; Fabin Han; Michel Panisset; Lemuel Racacho; Fengxia Xiao; Ruobi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract Multiple genes have been now identified as causing Parkinson's disease (PD). In 2003, two mutations were identified in exon 1 of the Nurr1 gene in 10 of 107 individuals with familial PD. To date, investigators have only focused on screening for these known mutations of the Nurr1 gene. A